Labor Analgesia With Ropivacaine and Clonidine
Information source: UPECLIN HC FM Botucatu Unesp
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Labor Pain
Intervention: ropivacaine (Drug); ropivacaine and clonidine (Drug)
Phase: N/A
Status: Completed
Sponsored by: UPECLIN HC FM Botucatu Unesp Official(s) and/or principal investigator(s):
Giane Nakamura, MD PHd, Principal Investigator, Affiliation: College Study of Medicine
Summary
The aim of the present study was to examine, for pain relief during labor, the efficacy of
two pharmacological approaches — the 0. 125% ropivacaine alone and the 0. 0625% ropivacaine
added to 75 ug clonidine, both by epidural administration. The effect of the drugs on mother
and newborn was also determined.
Clinical Details
Official title: Labor Analgesia With Ropivacaine Added to Clonidine. A Randomized Clinical Trial
Study design: Cohort, Prospective
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Singleton healthy
- Full-term pregnancy
- American Society of Anesthesiologists physical status I or II
Exclusion Criteria:
- Patients who had received opioids
- History of hypersensitivity to local anesthetic or to clonidine
- Fetus showed signs of possible intrauterine suffering
- Fetus showed signs of possible neurological deficit
Locations and Contacts
College of Medicine of Botucatu, Botucatu, São Paulo 18618970, Brazil
Additional Information
Starting date: May 2000
Ending date: December 2001
Last updated: February 28, 2008
|
